Open Access

Presence and role of Simian Virus 40 (SV40) in malignant pleural mesothelioma


Cite

de Olivera DE. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett 2007; 247: 182-96.10.1016/j.canlet.2006.05.01016814460Search in Google Scholar

Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000; 21: 405-26.10.1093/carcin/21.3.40510688861Search in Google Scholar

Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100.10.1126/science.1152586274091118202256Search in Google Scholar

Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 464-8.10.1038/2278010440377Search in Google Scholar

Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002; 2: 957-64.10.1038/nrc94712459734Search in Google Scholar

Eddy BE, Borman GS, Berkeley WH, Young RD. Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 1961; 107: 191-7.10.3181/00379727-107-2657613725644Search in Google Scholar

Vilchez RA, Butel JS. Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev 2004; 17: 495-508.10.1128/CMR.17.3.495-508.200445254915258090Search in Google Scholar

US NIH - NCI. Simian virus 40 and human cancer: questions and answers. http://www.cancer.gov/newscenter/sv40Search in Google Scholar

Shah KV. SV40 and human cancer: a review of recent data. Int J Cancer 2006; 120: 215-23.10.1002/ijc.2242517131333Search in Google Scholar

Leithner K, Leithner A, Clar H, Weinnaeusel A, Radl R, Krippl P, et al. Mesothelioma mortality in Europe: impact of asbestos consumption and Simian virus 40. Orph J Rare Dis 2006; 1: 44-55.10.1186/1750-1172-1-44166455217090323Search in Google Scholar

Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa J, et al. Human mesothelial cells are unusually susceptible to Simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci USA 2000; 97: 10214-9.10.1073/pnas.1702070972781810954737Search in Google Scholar

Bocchetta M, Eliasz S, Arakelian De Marco M, Rudzinski J, Zhang L, Carbone M. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res 2008; 68: 1022-9.10.1158/0008-5472.CAN-07-520318281476Search in Google Scholar

Manfredi JJ, Dong J, Liu W, Resnick-Silverman L, Qiao R, Chahinian P, Saric M, et al. Evidence against a role for SV40 in human mesothelioma. Cancer Res 2005; 65: 2602-9.10.1158/0008-5472.CAN-04-246115805256Search in Google Scholar

Carbone M, Pass HI, Miele L, Bocchetta M. New developments about the association of SV40 with human mesothelioma. Oncogene 2003; 22: 5173-80.10.1038/sj.onc.120655212910254Search in Google Scholar

Eržen J, Vidmar S, Sok M, Debeljak A, Kecelj P, Kovač V, et al. Surgical treatment of malignant pleural mesothelioma. Experience in the interdisciplinary approach in Slovenia. Radio Oncol 2005; 39: 123-31.Search in Google Scholar

Debevec M, Kovač V, Debeljak A, Eržen J, Remškar Z, Kern I. Maligni plevralni mezoteliom. Analiza bolnikov v Sloveniji 1980-1997. Zdrav Vestn 2000; 69: 599-606.Search in Google Scholar

Ćurin K, Šarić M, Strnad M. Incidence of malignant pleural mesothelioma in coastal and continental Croatia: epidemiological study. Croat Med J 2002; 43: 498-502.Search in Google Scholar

Churg A, Roggli V, Galateau-Salle F, Cagle P, Gibbs AR, Hasleton P, et al. Mesothelioma. In: Travis DW, Brambilla E, Muller-Hermelink HK, Harris CC, editors. WHO classification of tumours. Volume 10 - Pathology and genetics of tumours of the lung, pleura, thymus and heart. Geneva: WHO Press, 2004; p 128-36.Search in Google Scholar

McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996; 9: 1932-42.10.1183/09031936.96.090919328880114Search in Google Scholar

Kroczynska B, Curtone R, Bocchetta M, Yang H, Elmishad AG, Vacek P, et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and causing mesothelioma in hamsters. Proc Natl Acad Sci USA 2006; 103: 14128-33.10.1073/pnas.0604544103159992316966607Search in Google Scholar

Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJY, et al. Simian virus 40-like sequences in human mesothelioma. Oncogene 1994; 9: 1781-90.Search in Google Scholar

Engels EA, Viscidi RP, Galloway DA, Carter JJ, Cerhan JR, Davis S, et al. Case-control study of Simian virus 40 and non-Hodgkin lymphoma in the United States. J Nat Cancer Inst 2004; 96: 1368-74.10.1093/jnci/djh26615367569Search in Google Scholar

Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, et al. A multi-institutional study confirms the presence and expression of Simian virus 40 in human malignant mesotheliomas. Cancer Res 1998; 58: 4505-9.Search in Google Scholar

Burmeister B, Schwerdtle T, Poser I, Hoffmann E, Hartwig A, Müller W-U, et al. Effects of asbestos initiation of DNA damage, induction of DNA-strand breaks, p53-expression and apoptosis in primary, SV40-transformed and malignant human mesothelial cells. Mutat Res 2004; 558: 81-92.10.1016/j.mrgentox.2003.11.00315036122Search in Google Scholar

Moens U, Van Ghelue M, Johannessen M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci 2007; 64: 1656-78.10.1007/s00018-007-7020-317483871Search in Google Scholar

Ziegler A, Seemayer CA, Hinterberger M, Vogt P, Bigosch C, Gautschi O, et al. Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung Cancer 2007; 57: 282-91.10.1016/j.lungcan.2007.03.02517513005Search in Google Scholar

Lednicky JA, Butel JS. Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. Dev Biol Stand 1998; 94: 155-64.Search in Google Scholar

eISSN:
1581-3207
ISSN:
1318-2099
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Radiology, Internal Medicine, Haematology, Oncology